What’s Holding Back Women’s Health?
July 29, 2026
Women’s health is often discussed through the narrow lens of reproductive health. But the real scope of women’s health is much broader than that. In this episode of Biology Matters, host Rowan Gardner, Co-Founder of PrecisionLife, speaks with Chief Medical Officer, Dr. Veronique Bouchet, about why women’s health must be understood across the full spectrum of complex chronic disease. They explore why conditions ranging from cardiovascular disease and autoimmune disease to migraines, Alzheimer’s disease, and endometriosis require deeper biological understanding, better research, earlier diagnosis and more precise treatment pathways. Our healthcare systems are often working with incomplete data and this contributes to diagnostic delays. Could precision medicine help clinicians, patients, researchers, pharma and investors move toward better outcomes? Tune in to find out.
Women’s health is often reduced to reproductive health, excluding the wider reality of how complex chronic diseases affect women across their lives. In this episode of Biology Matters, Rowan Gardner speaks with Dr. Veronique Bouchet, Chief Medical Officer at PrecisionLife, about the need to understand women’s health through a broader, biology-first lens. The conversation explores why diagnosis can be so difficult in overwhelmed healthcare systems, how clinicians are often working within pathways that were not designed around the complexity of women’s biology and how precision medicine can help solve the dearth of fast, accessible and non-invasive diagnostic tools that can help match patients to the right care earlier.
What You'll Learn:
- Why women’s health needs rethinking beyond reproductive medicine
- How common conditions such as depression, cardiovascular disease, autoimmune disease, migraine and Alzheimer’s disease affect women differently
- Why diagnostic delay is common in complex women’s health conditions such as endometriosis
- How incomplete biological data limits research, clinical trials and treatment development
- Why investment in women’s health has historically focused on too narrow areas of care
- Why better stratification can help clinicians, patients, pharma, biotech and healthcare systems move forward together
About Rowan
Rowan Gardner is Chief Business and Investment Officer and Co-Founder of Precision Life, bringing 30+ years of experience across health tech, digital health, deep tech and biotech. Her expertise spans securing venture funding, building strategic partnerships and translating breakthrough science into real-world healthcare impact across multiple continents. Her insights into what leading health systems worldwide are doing differently provide actionable guidance for clinical leaders seeking to implement mechanism-based strategies that improve outcomes while reducing healthcare costs.
About Veronique
Dr. Veronique Bouchet is Chief Medical Officer at PrecisionLife and a physician executive with more than three decades of international experience across biopharma, digital health, venture strategy and precision medicine. Her clinical background spans obstetrics, gynaecology, paediatrics and general medicine, giving her a broad view of the health challenges women face across adolescence, childbearing years, menopause and later life. Over the course of her career, Veronique has focused on translating scientific advances into practical patient impact, with a particular interest in complex chronic disease and women’s health.
Her work reflects the central belief that better understanding of biology can help healthcare move from broad symptom management toward earlier diagnosis, stratified treatment and more precise care.
Episode Resources:
Biology Matters is handcrafted by our friends over at: fame.so